The goal of this program is to improve the utility of circulating tumor DNA (ctDNA) analysis in patients with colon cancer. After hearing and assimilating this program, the clinician will be better able to:Explain the potential role of ctDNA as a biomarker in colon cancer.Compare use of tumor-informed vs -uninformed assays in ctDNA testing.Cite evidence from the DYNAMIC trial regarding outcomes using ctDNA-guided adjuvant chemotherapy in stage II colon cancer.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2024-07-23 05:00:00
- End Date: 2024-07-23 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- MOC Credit Details: ABIM - 0.75 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest